CN102256602A - 用于治疗上皮组织的组合物 - Google Patents

用于治疗上皮组织的组合物 Download PDF

Info

Publication number
CN102256602A
CN102256602A CN2009801527052A CN200980152705A CN102256602A CN 102256602 A CN102256602 A CN 102256602A CN 2009801527052 A CN2009801527052 A CN 2009801527052A CN 200980152705 A CN200980152705 A CN 200980152705A CN 102256602 A CN102256602 A CN 102256602A
Authority
CN
China
Prior art keywords
pharmaceutical composition
topiramate
skin
scar
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801527052A
Other languages
English (en)
Chinese (zh)
Inventor
N·A·沙皮拉
A·巴齐莱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novodermix International Ltd
Original Assignee
Novodermix International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novodermix International Ltd filed Critical Novodermix International Ltd
Publication of CN102256602A publication Critical patent/CN102256602A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2009801527052A 2008-10-21 2009-10-21 用于治疗上皮组织的组合物 Pending CN102256602A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13699408P 2008-10-21 2008-10-21
US61/136994 2008-10-21
PCT/IB2009/054646 WO2010046861A1 (en) 2008-10-21 2009-10-21 Composition for treatment of epithelial tissue

Publications (1)

Publication Number Publication Date
CN102256602A true CN102256602A (zh) 2011-11-23

Family

ID=42118987

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801527052A Pending CN102256602A (zh) 2008-10-21 2009-10-21 用于治疗上皮组织的组合物

Country Status (9)

Country Link
US (1) US20110257257A1 (enExample)
EP (1) EP2361083A4 (enExample)
JP (1) JP2012506417A (enExample)
KR (1) KR20110074611A (enExample)
CN (1) CN102256602A (enExample)
BR (1) BRPI0914454A2 (enExample)
CA (1) CA2741028A1 (enExample)
RU (1) RU2011120054A (enExample)
WO (1) WO2010046861A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104603616A (zh) * 2012-09-07 2015-05-06 株式会社资生堂 使用纤蛋白-3和/或肌聚糖γ作为指标评价脂肪团的方法和评价脂肪团有效药物的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9962391B2 (en) 2011-12-27 2018-05-08 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213500B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US10813897B2 (en) 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213501B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US9468599B2 (en) 2011-12-27 2016-10-18 Cmpd Licensing, Llc Composition and method for compounded therapy
CN105073860B (zh) 2013-02-26 2018-09-21 旭化成建材株式会社 酚醛树脂发泡板及其制造方法
WO2022204350A1 (en) * 2021-03-24 2022-09-29 Orgenesis Inc. Compositions comprising topiramate for treating dermatological conditions
CN115245470A (zh) * 2021-04-27 2022-10-28 山东本真化妆品有限公司 水包油乳液及其在对抗婴儿湿疹中的用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage
CN1646538A (zh) * 2002-02-15 2005-07-27 奥索-麦克尼尔药品公司 托吡酯盐及其组合物、制备方法和应用
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US4323694A (en) * 1981-04-13 1982-04-06 Finetex, Inc. Benzoic acid esters
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin
US20020082222A1 (en) * 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
FR2829693B1 (fr) * 2001-09-20 2004-02-27 Oreal Creme cosmetique moussante
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
ES2532906T5 (es) * 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
US6949518B1 (en) * 2003-06-25 2005-09-27 Pao-Hsien Chu Methods for treating macular degeneration with topiramate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1646538A (zh) * 2002-02-15 2005-07-27 奥索-麦克尼尔药品公司 托吡酯盐及其组合物、制备方法和应用
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104603616A (zh) * 2012-09-07 2015-05-06 株式会社资生堂 使用纤蛋白-3和/或肌聚糖γ作为指标评价脂肪团的方法和评价脂肪团有效药物的方法

Also Published As

Publication number Publication date
EP2361083A4 (en) 2013-11-20
BRPI0914454A2 (pt) 2015-10-27
EP2361083A1 (en) 2011-08-31
US20110257257A1 (en) 2011-10-20
RU2011120054A (ru) 2012-11-27
CA2741028A1 (en) 2010-04-29
KR20110074611A (ko) 2011-06-30
WO2010046861A1 (en) 2010-04-29
JP2012506417A (ja) 2012-03-15

Similar Documents

Publication Publication Date Title
CN102256602A (zh) 用于治疗上皮组织的组合物
JP6966455B2 (ja) 侵襲的且つ非侵襲的な処置上のスキンケアのための組成物及び方法
AU2016222802B2 (en) Reduction of adipose tissue
RU2691412C2 (ru) Способы и композиции для лечения болезни сухого глаза и других глазных заболеваний
CA3153934C (en) Treatment of skin conditions using high krafft temperature anionic surfactants
CN1188119C (zh) 用于减少眼睛下部黑眼圈出现的方法
JP7421558B2 (ja) 組織修復に適用されるピルフェニドンを含有する半固体油性医薬組成物
TW201210601A (en) Compounds and methods for skin repair
CN102421428B (zh) 用于防止脱发或促进毛发生长的组合物
CN104800150A (zh) 一种米诺地尔乳膏剂及制备方法
US20150283080A1 (en) Stabilized dermatological delivery system for active ingredient compositions for topical administration to the skin
CN103816165A (zh) 一种治疗痤疮的组合物
JP2002255725A (ja) 皮膚の処置
JP2024542045A (ja) 汎ｂｅｔ阻害剤の使用
US20060127429A1 (en) Topical numbing composition for laser therapy
CN102105142A (zh) 用于治疗红斑狼疮的包括壳聚糖和二羧酸的组合物
US20150306221A1 (en) Mixture of Betamethasone and Tranilast with a Transdermal Gel for Scar Treatment
US20140315991A1 (en) Composition for treatment of epithelial tissue
KR102221499B1 (ko) 위축성 피부 흉터를 치료하기 위한 프로스타글라딘 F2α 및 그 유사체
US20140350117A1 (en) Topical Scar Treatment Composition and Method of Using Same
KR20160117529A (ko) 헤파린의 국소 제제
JP3658114B2 (ja) 皮膚外用剤
WO2022131079A1 (ja) 外用組成物
KR20250083499A (ko) 통증 및 다른 의학적 병태의 치료를 위한 황화 글리코사미노글리칸 및 이것에서 유래한 단편의 저장에 안정한 제형
CN117427006A (zh) 包含青蒿提取物和油溶性成分的组合物及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111123